Komori
Occurring Fact4933I-ne CO.,LTD.Materials and Chemicals

Notice Regarding the Formulation of Measures to Prevent Recurrence

Following the Special Investigation Committee’s analysis of the causes of the issues it identified and its recommendations for preventing recurrence, the Company’s Board of Directors resolved specific measures to prevent recurrence. The Company will review its governance framework, Board of Directors’ oversight, related-party transactions, information management and other areas, and plans to transition these measures to the operational stage by the end of December 2026.

Worth reading
54Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Neutral
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Conditional
How definitive the wording is.

Formulation of measures to prevent recurrence

Subject Entity

株式会社I-ne (the filing company)

Occurrence15 May 2026 (the date on which the Board of Directors resolved the measures to prevent recurrence)
This disclosure05/15/2026
Cause

Insufficient awareness and understanding of governance and compliance among the Representative Director and senior members of the executive side; concentration of authority in the Representative Director and a homogeneous management team; insufficient mechanisms to ensure the effectiveness of deliberations and oversight by the Board of Directors; deficiencies in the organizational management framework for related-party transactions; deficiencies in mechanisms for escalating concerns; deficiencies in the information management framework; and deficiencies in awareness and systems concerning the preservation of data and cooperation with investigations

Company response

Investigation structure

Special Investigation Committee (establishment date and chairperson’s name: Not disclosed)

Measures to prevent recurrence

Change to a structure in which an independent outside director serves as Chair of the Board of Directors; consider and establish selection criteria for director candidates that include governance and compliance awareness, and build a system under which the Nomination and Compensation Committee assesses candidates’ suitability against those criteria; incorporate governance and compliance factors into the compensation and evaluation of directors; consider applying or adapting these measures to the appointment, compensation and evaluation of executive officers; conduct regular governance and compliance training for directors and executive officers; conduct governance and compliance training for all employees; specifically identify and expand situations in which the internal whistleblowing system may be used, and reiterate its availability while expressly stating that whistleblowers will not suffer any disadvantage; consider measures to improve the effectiveness of the Board of Directors, including prior coordination with the Chair regarding the agendas and materials for important meetings; review whether the approval criteria for matters subject to the Representative Director’s sole authority are appropriate, including, as necessary, transferring such matters to those requiring a Board of Directors resolution or making them conditional on prior consultation with and recommendations from the Executive Officers’ Meeting; establish and operate separate rules for the comprehensive identification and management of related-party transactions; enhance the questionnaires used in the investigation process concerning related parties (implemented as of the date of this disclosure); expand monitoring functions based on a risk-based approach for transactions that inherently carry the potential for conflicts of interest; and strengthen the information management framework, including measures to preserve business data and establish rules governing IT tools used for business operations

Directors' and officers' liability

Ohnishi Yohei (大西洋平), Representative Director, President and CEO, will voluntarily return 100% of his executive compensation until the Company confirms the steady implementation of the measures to prevent recurrence. The period of voluntary return is planned to run through the end of December 2026.

Related procedures

Type

Investigation by the Special Investigation Committee

Outlook

The Company plans to transition the measures to prevent recurrence to the operational stage by the end of December 2026. It will implement the measures steadily and make every effort to restore trust at an early date.

Event that occurred
ItemDetails
Event nameFormulation of measures to prevent recurrence
Date of occurrence15 May 2026 (the date on which the Board of Directors resolved the measures to prevent recurrence)
Subject Entity株式会社I-ne (the filing company)
CauseInsufficient awareness and understanding of governance and compliance among the Representative Director and senior members of the executive side; concentration of authority in the Representative Director and a homogeneous management team; insufficient mechanisms to ensure the effectiveness of deliberations and oversight by the Board of Directors; deficiencies in the organizational management framework for related-party transactions; deficiencies in mechanisms for escalating concerns; deficiencies in the information management framework; and deficiencies in awareness and systems concerning the preservation of data and cooperation with investigations
Type of litigation or proceedingInvestigation by the Special Investigation Committee
Investigation structureSpecial Investigation Committee (establishment date and chairperson’s name: Not disclosed)
Measures to prevent recurrenceChange to a structure in which an independent outside director serves as Chair of the Board of Directors; consider and establish selection criteria for director candidates that include governance and compliance awareness, and build a system under which the Nomination and Compensation Committee assesses candidates’ suitability against those criteria; incorporate governance and compliance factors into the compensation and evaluation of directors; consider applying or adapting these measures to the appointment, compensation and evaluation of executive officers; conduct regular governance and compliance training for directors and executive officers; conduct governance and compliance training for all employees; specifically identify and expand situations in which the internal whistleblowing system may be used, and reiterate its availability while expressly stating that whistleblowers will not suffer any disadvantage; consider measures to improve the effectiveness of the Board of Directors, including prior coordination with the Chair regarding the agendas and materials for important meetings; review whether the approval criteria for matters subject to the Representative Director’s sole authority are appropriate, including, as necessary, transferring such matters to those requiring a Board of Directors resolution or making them conditional on prior consultation with and recommendations from the Executive Officers’ Meeting; establish and operate separate rules for the comprehensive identification and management of related-party transactions; enhance the questionnaires used in the investigation process concerning related parties (implemented as of the date of this disclosure); expand monitoring functions based on a risk-based approach for transactions that inherently carry the potential for conflicts of interest; and strengthen the information management framework, including measures to preserve business data and establish rules governing IT tools used for business operations
Directors' and officers' liabilityOhnishi Yohei (大西洋平), Representative Director, President and CEO, will voluntarily return 100% of his executive compensation until the Company confirms the steady implementation of the measures to prevent recurrence. The period of voluntary return is planned to run through the end of December 2026.
OutlookThe Company plans to transition the measures to prevent recurrence to the operational stage by the end of December 2026. It will implement the measures steadily and make every effort to restore trust at an early date.
Items this document does not state (16)
Date recognized / date notice receivedTarget Locations / ProductsAmount of Impact on Business PerformanceAccounting period in which recognizedImpact on Earnings ForecastCourt or authorityPlaintiffDefendantDate of filing / date of actionClaim amount / surcharge amountAmount of receivables at risk of non-collection or delayed collectionSuspended operationsScheduled resumption dateVoting rights ownership percentage before the changeVoting rights ownership percentage after the changePlanned follow-up disclosure

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The Company took seriously the analysis of the causes of the issues identified in the Special Investigation Committee’s investigation report and its recommendations for preventing recurrence.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Regarding the Formulation of Measures to Prevent Recurrence | I-ne CO.,LTD. (4933) timely disclosure | Komori